ProBioGen and Evotec Technologies Announce Successful Completion of Collaboration on Automated Cell Selection Technology
ProBioGen AG and Evotec Technologies GmbH have announced the successful completion of their collaboration - the joint evaluation of methods and instrumentation for the selection of high producer cells. ProBioGen could show based on it's cell-based assay technology, know how and expertise in cGMP cell culture that Evotec's Cytocon(TM) device can be employed for the selection of high producer cell lines used in pharmaceutical development and manufacturing applications.
Both companies emphasize their great satisfaction with the mutually inspiring and successful cooperation, and scientists from both companies professed their interest in future common projects.
Most read news
Other news from the department business & finance
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Detecting tiny twists with a nanomachine - Nanoscale device may reveal spin-dependent fundamental forces and provide new methods of characterizing torque-generating molecules and DNA strands